Glibenclamide, acute/long-term response in M.O. diabetics.
作者信息
Owens D R, Wragg K G, Shetty K T, Biggs P I, Davies C D
出版信息
Horm Metab Res. 1979 Jun;11(6):411-2. doi: 10.1055/s-0028-1095784.
PMID:112018
Abstract
摘要
相似文献
1
Glibenclamide, acute/long-term response in M.O. diabetics.
Horm Metab Res. 1979 Jun;11(6):411-2. doi: 10.1055/s-0028-1095784.
2
[Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy].
Clin Ter. 1978 Jun 30;85(6):550-8.
3
4
Glucose, FFA, IRI and GH response to I.V. glibenclamide.
Horm Metab Res. 1973 Jul;5(4):303. doi: 10.1055/s-0028-1096743.
5
Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.格列戊脲（司达立）与格列本脲治疗糖尿病的临床比较
Curr Ther Res Clin Exp. 1977 Jan;21(1):50-7.
6
Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.老年糖尿病患者在格列本脲和格列吡嗪治疗期间血浆胰岛素和血糖的昼夜变化模式。
Acta Endocrinol Suppl (Copenh). 1980;239:44-52.
7
[Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin].
Minerva Med. 1975 Mar 14;66(19):940-5.
8
[Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
Acta Diabetol Lat. 1973 Jan-Feb;10(1):30-53. doi: 10.1007/BF02590651.
9
[Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
Clin Ter. 1992 Mar;140(3):259-63.
10
[Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
Verh Dtsch Ges Inn Med. 1977;83:1388-91.
Zotero 插件